Test Bank - Pharmacology: A Patient-Centered Nursing
Process Approach (9th Edition) PHARMACOLOGY 9TH
EDITION MCCUISTION TEST BANK
Table of Contents
Table of Contents Chapter 28: Peptides, Antimalarial, and
Chapter 01: Drug Development and Anthelmintic
Ethical Considerations Chapter 29: HIV- and AIDS-Related
Chapter 02: Pharmacokinetics, Drugs
Pharmacodynamics, and Chapter 30: Transplant Drugs
Pharmacogenetics Chapter 31: Vaccines
Chapter 03: Cultural Considerations Chapter 32: Anticancer Drugs
Chapter 04: Complementary and Chapter 33: Targeted Therapies to Treat
Alternative Therapies Cancer
Chapter 05: Pediatric Considerations Chapter 34: Biologic Response
Chapter 06: Geriatric Considerations Modifiers
Chapter 07: Drugs in Substance Use Chapter 35: Upper Respiratory
Disorder Disorders
Chapter 08: The Nursing Process and Chapter 36: Lower Respiratory
Patient-Centered Care Disorders
Chapter 09: Safety and Quality Chapter 37: Cardiac Glycosides,
Chapter 10: Drug Administration Antianginals, and Antidysrhythmics
Chapter 11: Drug Calculations Chapter 38: Diuretics
Chapter 12: Fluid Volume and Chapter 39: Antihypertensive
Electrolytes Chapter 40: Anticoagulants,
Chapter 13: Vitamin and Mineral Antiplatelets, and Thrombolytics
Replacement Chapter 41: Antihyperlipidemics and
Chapter 14: Nutritional Support Peripheral Vasodilators
Chapter 15: Adrenergic Agonists and Chapter 42: Gastrointestinal Tract
Antagonists Disorders
Chapter 16: Cholinergic Agonists and Chapter 43: Antiulcer Drugs
Antagonists Chapter 44: Eye and Ear Disorders
Chapter 17: Stimulants Chapter 45: Dermatologic Disorders
Chapter 18: Depressants Chapter 46: Pituitary, Thyroid,
Chapter 19: Antiseizure Drugs Parathyroid, and Adrenal Disorders
Chapter 20: Drugs for Parkinsonism and Chapter 47: Antidiabetics
Alzheimer's Disease Chapter 48: Urinary Disorders
Chapter 21: Drugs for Neuromuscular Chapter 49: Pregnancy and Preterm
Disorders and Muscle Spasms Labor
Chapter 22: Antipsychotics and Chapter 50: Labor, Delivery, and
Anxiolytics Postpartum
Chapter 23: Antidepressants and Mood Chapter 51: Neonatal and Newborn
Stabilizers Chapter 52: Women's Reproductive
Chapter 24: Antiinflammatories Health
Chapter 25: Analgesics Chapter 53: Men's Reproductive Health
Chapter 26: Antibacterials Chapter 54: Sexually Transmitted
Chapter 27: Antituberculars, Antifungals, Infections
and Antivirals Chapter 55: Adult and Pediatric
Emergency Drugs
,Test Bank - Pharmacology: A Patient-Centered Nursing Process Approach (9th Edition,
2017)
PHARMACOLOGY 9TH EDITION MCCUISTION TEST BANK
Chapter 01: Drug Development and Ethical Considerations
MULTIPLE CHOICE
1. The nurse is preparing to administer a schedule II injectable drug and is drawing up half of
the contents of a Single-use vial. Which nursing action is correct?
a. Ask another nurse to observe and cosign wasting the remaining drug from the vial.
b. Keep the remaining amount in the patient’s drawer to give at the next dose.
c. Record the amount unused in the patient’s medication record.
d. Dispose of the vial with the remaining drug into a locked collection box.
ANS: A
Schedule II drugs are controlled substances, and all must be accounted for. When wasting a
portion of a drug, another nurse should observe and cosign that a drug was wasted.
DIF: COGNITIVE LEVEL: Applying (Application)
TOP: NURSING PROCESS: Nursing Intervention
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
2. A patient is prescribed a medication and asks the nurse if the drug is available in a generic
form. The nurse understands that a generic medication will have a name that
a. is a registered trademark.
b. is always capitalized.
c. describes the drugs chemical structure.
d. is non-proprietary.
ANS: D
The generic name is the official, non-proprietary name for a drug. The brand name is the
trademark name and is always capitalized. The chemical name describes the chemical structure
of the drug.
DIF: COGNITIVE LEVEL: Understanding (Comprehension)
TOP: NURSING PROCESS: N/A
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
3. A patient receives a prescription on which the provider has noted that a generic
medicationmay be given.The patient asks the nurse what this means. What will the nurse tell
the patientabout generic drugs?
a. They contain the same inert ingredients as brand-name drugs.
b. They have chemical structures that are identical to proprietary drugs.
c. They tend to be less expensive than brand-name drugs.
d. They undergo extensive testing before they are marketed.
ANS: C
Generic drugs are approved by the FDA if they are proved to be bioequivalent to the brand-
name drug. They tend to be less expensive because manufacturers of these drugs do not have
to do the extensive testing required of brand-name drugs before marketing. They are not
identical to brand-name drugs and often have different inert ingredients.
DIF: COGNITIVE LEVEL: Applying (Application)
TOP: NURSING PROCESS: Nursing Intervention: Patient Teaching
MSC: NCLEX: Management of Client Care
4. The nurse reviews information about a drug and notes the initials USP after the drugs official
name. The nurse understands that this designation indicates the drug
a. is a controlled substance.
,Test Bank - Pharmacology: A Patient-Centered Nursing Process Approach (9th Edition,
2017)
PHARMACOLOGY 9TH EDITION MCCUISTION TEST BANK
b. is approved by the U.S. Food and Drug Administration (FDA).
c. is available in generic form.
d. meets quality and safety standards.
ANS: D
The USP designation is given to drugs that have met high standards for therapeutic use, patient
safety, quality, purity, strength, packaging safety, and dosage form by the United States
Pharmacopoeia National Formulary. The FDA classifies controlled substances with Roman
numerals from I to V. The USP designation does not indicate FDA approval. The USP
designation does not indicate generic availability.
DIF: COGNITIVE LEVEL: Understanding (Comprehension)
TOP: NURSING PROCESS: N/A
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
5. The nurse is preparing to give a medication to a child. The child’s parent asks whether the
drug is safe for children. How will the nurse respond to the parent?
a. Drugs are tested on adults and safe doses for children are based on weights compared to
adult weights.
b. Drugs are deemed safe for children over time when repeated use proves effectiveness and
safety.
c. Drugs are tested for both efficacy and safety in children in order to be marketed for pediatric
use.
d. Drugs are tested on children in post marketing studies and on a limited basis.
ANS: C
The Pediatric Research Equity Act requires drug manufacturers to test drugs on children.
DIF: COGNITIVE LEVEL: Applying (Application)
TOP: NURSING PROCESS: Nursing Intervention
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
6. Which law(s) govern all drug administration by nurses?
a. Drug Regulation and Reform Act
b. FDA Amendments Act
c. Nurse Practice Acts
d. The Controlled Substances Act
ANS: C
Each states Nurse Practice Act identifies how nurses administer medications. The other acts
govern how drugs are marketed and tested.
DIF: COGNITIVE LEVEL: Understanding (Comprehension)
TOP: NURSING PROCESS: N/A
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
7. The nurse administers a drug and miscalculates the dose by placing the decimal place one
space to the right, resulting in a 10-fold overdose and the death of the patient. What offense
does this represent?
a. Malfeasance
b. Malpractice
c. Misfeasance
d. Nonfeasance
ANS: C
Misfeasance is negligence in giving either the wrong drug or the wrong dose, resulting in the
death of the patient.
, Test Bank - Pharmacology: A Patient-Centered Nursing Process Approach (9th Edition,
2017)
PHARMACOLOGY 9TH EDITION MCCUISTION TEST BANK
DIF: COGNITIVE LEVEL: Understanding (Comprehension)
TOP: NURSING PROCESS: N/A
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
8. The nurse is busy and neglects to give a drug to a patient resulting in the patient’s death.
What offense does this represent?
a. Malfeasance
b. Malpractice
c. Misfeasance
d. Nonfeasance
ANS: D
Nonfeasance is omitting a drug dose, resulting in the patient’s death.
DIF: COGNITIVE LEVEL: Understanding (Comprehension)
TOP: NURSING PROCESS: N/A
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
9. A patient is taking methadone as part of a heroin withdrawal program. The nurse understands
that, in this instance, methadone is classified as which drug schedule?
a. C-I
b. C-II
c. C-III
d. C-V
ANS: B
Methadone is a category II drug, with a high potential for drug abuse.
DIF: COGNITIVE LEVEL: Understanding (Comprehension)
TOP: NURSING PROCESS: N/A
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
10. The nurse is preparing to administer a combination drug containing acetaminophen and
codeine. The nurse
knows that this drug is classified as which drug schedule?
a. C-II
b. C-III
c. C-IV
d. C-V
ANS: B
Codeine is normally a category II drug, except when it is part of a combination product such as
with acetaminophen, making it a category III drug.
DIF: COGNITIVE LEVEL: Understanding (Comprehension)
TOP: NURSING PROCESS: N/A
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
11. The nurse is obtaining consent from a subject newly recruited for a clinical drug trial that will
last for 6 months. All subjects will be given gift certificates for participating. One subject says,
Well, I guess if the drug doesn't work, I'll just have to put up with the symptoms for 6 months.
What will the nurse tell the subject?
a. Participation for the duration of the study is required.
b. Participation may end at any time without penalty.
c. Withdrawal from the study may end at any time, but the gift certificate will not be given.
d. You can request placement in the treatment group.
Process Approach (9th Edition) PHARMACOLOGY 9TH
EDITION MCCUISTION TEST BANK
Table of Contents
Table of Contents Chapter 28: Peptides, Antimalarial, and
Chapter 01: Drug Development and Anthelmintic
Ethical Considerations Chapter 29: HIV- and AIDS-Related
Chapter 02: Pharmacokinetics, Drugs
Pharmacodynamics, and Chapter 30: Transplant Drugs
Pharmacogenetics Chapter 31: Vaccines
Chapter 03: Cultural Considerations Chapter 32: Anticancer Drugs
Chapter 04: Complementary and Chapter 33: Targeted Therapies to Treat
Alternative Therapies Cancer
Chapter 05: Pediatric Considerations Chapter 34: Biologic Response
Chapter 06: Geriatric Considerations Modifiers
Chapter 07: Drugs in Substance Use Chapter 35: Upper Respiratory
Disorder Disorders
Chapter 08: The Nursing Process and Chapter 36: Lower Respiratory
Patient-Centered Care Disorders
Chapter 09: Safety and Quality Chapter 37: Cardiac Glycosides,
Chapter 10: Drug Administration Antianginals, and Antidysrhythmics
Chapter 11: Drug Calculations Chapter 38: Diuretics
Chapter 12: Fluid Volume and Chapter 39: Antihypertensive
Electrolytes Chapter 40: Anticoagulants,
Chapter 13: Vitamin and Mineral Antiplatelets, and Thrombolytics
Replacement Chapter 41: Antihyperlipidemics and
Chapter 14: Nutritional Support Peripheral Vasodilators
Chapter 15: Adrenergic Agonists and Chapter 42: Gastrointestinal Tract
Antagonists Disorders
Chapter 16: Cholinergic Agonists and Chapter 43: Antiulcer Drugs
Antagonists Chapter 44: Eye and Ear Disorders
Chapter 17: Stimulants Chapter 45: Dermatologic Disorders
Chapter 18: Depressants Chapter 46: Pituitary, Thyroid,
Chapter 19: Antiseizure Drugs Parathyroid, and Adrenal Disorders
Chapter 20: Drugs for Parkinsonism and Chapter 47: Antidiabetics
Alzheimer's Disease Chapter 48: Urinary Disorders
Chapter 21: Drugs for Neuromuscular Chapter 49: Pregnancy and Preterm
Disorders and Muscle Spasms Labor
Chapter 22: Antipsychotics and Chapter 50: Labor, Delivery, and
Anxiolytics Postpartum
Chapter 23: Antidepressants and Mood Chapter 51: Neonatal and Newborn
Stabilizers Chapter 52: Women's Reproductive
Chapter 24: Antiinflammatories Health
Chapter 25: Analgesics Chapter 53: Men's Reproductive Health
Chapter 26: Antibacterials Chapter 54: Sexually Transmitted
Chapter 27: Antituberculars, Antifungals, Infections
and Antivirals Chapter 55: Adult and Pediatric
Emergency Drugs
,Test Bank - Pharmacology: A Patient-Centered Nursing Process Approach (9th Edition,
2017)
PHARMACOLOGY 9TH EDITION MCCUISTION TEST BANK
Chapter 01: Drug Development and Ethical Considerations
MULTIPLE CHOICE
1. The nurse is preparing to administer a schedule II injectable drug and is drawing up half of
the contents of a Single-use vial. Which nursing action is correct?
a. Ask another nurse to observe and cosign wasting the remaining drug from the vial.
b. Keep the remaining amount in the patient’s drawer to give at the next dose.
c. Record the amount unused in the patient’s medication record.
d. Dispose of the vial with the remaining drug into a locked collection box.
ANS: A
Schedule II drugs are controlled substances, and all must be accounted for. When wasting a
portion of a drug, another nurse should observe and cosign that a drug was wasted.
DIF: COGNITIVE LEVEL: Applying (Application)
TOP: NURSING PROCESS: Nursing Intervention
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
2. A patient is prescribed a medication and asks the nurse if the drug is available in a generic
form. The nurse understands that a generic medication will have a name that
a. is a registered trademark.
b. is always capitalized.
c. describes the drugs chemical structure.
d. is non-proprietary.
ANS: D
The generic name is the official, non-proprietary name for a drug. The brand name is the
trademark name and is always capitalized. The chemical name describes the chemical structure
of the drug.
DIF: COGNITIVE LEVEL: Understanding (Comprehension)
TOP: NURSING PROCESS: N/A
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
3. A patient receives a prescription on which the provider has noted that a generic
medicationmay be given.The patient asks the nurse what this means. What will the nurse tell
the patientabout generic drugs?
a. They contain the same inert ingredients as brand-name drugs.
b. They have chemical structures that are identical to proprietary drugs.
c. They tend to be less expensive than brand-name drugs.
d. They undergo extensive testing before they are marketed.
ANS: C
Generic drugs are approved by the FDA if they are proved to be bioequivalent to the brand-
name drug. They tend to be less expensive because manufacturers of these drugs do not have
to do the extensive testing required of brand-name drugs before marketing. They are not
identical to brand-name drugs and often have different inert ingredients.
DIF: COGNITIVE LEVEL: Applying (Application)
TOP: NURSING PROCESS: Nursing Intervention: Patient Teaching
MSC: NCLEX: Management of Client Care
4. The nurse reviews information about a drug and notes the initials USP after the drugs official
name. The nurse understands that this designation indicates the drug
a. is a controlled substance.
,Test Bank - Pharmacology: A Patient-Centered Nursing Process Approach (9th Edition,
2017)
PHARMACOLOGY 9TH EDITION MCCUISTION TEST BANK
b. is approved by the U.S. Food and Drug Administration (FDA).
c. is available in generic form.
d. meets quality and safety standards.
ANS: D
The USP designation is given to drugs that have met high standards for therapeutic use, patient
safety, quality, purity, strength, packaging safety, and dosage form by the United States
Pharmacopoeia National Formulary. The FDA classifies controlled substances with Roman
numerals from I to V. The USP designation does not indicate FDA approval. The USP
designation does not indicate generic availability.
DIF: COGNITIVE LEVEL: Understanding (Comprehension)
TOP: NURSING PROCESS: N/A
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
5. The nurse is preparing to give a medication to a child. The child’s parent asks whether the
drug is safe for children. How will the nurse respond to the parent?
a. Drugs are tested on adults and safe doses for children are based on weights compared to
adult weights.
b. Drugs are deemed safe for children over time when repeated use proves effectiveness and
safety.
c. Drugs are tested for both efficacy and safety in children in order to be marketed for pediatric
use.
d. Drugs are tested on children in post marketing studies and on a limited basis.
ANS: C
The Pediatric Research Equity Act requires drug manufacturers to test drugs on children.
DIF: COGNITIVE LEVEL: Applying (Application)
TOP: NURSING PROCESS: Nursing Intervention
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
6. Which law(s) govern all drug administration by nurses?
a. Drug Regulation and Reform Act
b. FDA Amendments Act
c. Nurse Practice Acts
d. The Controlled Substances Act
ANS: C
Each states Nurse Practice Act identifies how nurses administer medications. The other acts
govern how drugs are marketed and tested.
DIF: COGNITIVE LEVEL: Understanding (Comprehension)
TOP: NURSING PROCESS: N/A
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
7. The nurse administers a drug and miscalculates the dose by placing the decimal place one
space to the right, resulting in a 10-fold overdose and the death of the patient. What offense
does this represent?
a. Malfeasance
b. Malpractice
c. Misfeasance
d. Nonfeasance
ANS: C
Misfeasance is negligence in giving either the wrong drug or the wrong dose, resulting in the
death of the patient.
, Test Bank - Pharmacology: A Patient-Centered Nursing Process Approach (9th Edition,
2017)
PHARMACOLOGY 9TH EDITION MCCUISTION TEST BANK
DIF: COGNITIVE LEVEL: Understanding (Comprehension)
TOP: NURSING PROCESS: N/A
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
8. The nurse is busy and neglects to give a drug to a patient resulting in the patient’s death.
What offense does this represent?
a. Malfeasance
b. Malpractice
c. Misfeasance
d. Nonfeasance
ANS: D
Nonfeasance is omitting a drug dose, resulting in the patient’s death.
DIF: COGNITIVE LEVEL: Understanding (Comprehension)
TOP: NURSING PROCESS: N/A
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
9. A patient is taking methadone as part of a heroin withdrawal program. The nurse understands
that, in this instance, methadone is classified as which drug schedule?
a. C-I
b. C-II
c. C-III
d. C-V
ANS: B
Methadone is a category II drug, with a high potential for drug abuse.
DIF: COGNITIVE LEVEL: Understanding (Comprehension)
TOP: NURSING PROCESS: N/A
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
10. The nurse is preparing to administer a combination drug containing acetaminophen and
codeine. The nurse
knows that this drug is classified as which drug schedule?
a. C-II
b. C-III
c. C-IV
d. C-V
ANS: B
Codeine is normally a category II drug, except when it is part of a combination product such as
with acetaminophen, making it a category III drug.
DIF: COGNITIVE LEVEL: Understanding (Comprehension)
TOP: NURSING PROCESS: N/A
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
11. The nurse is obtaining consent from a subject newly recruited for a clinical drug trial that will
last for 6 months. All subjects will be given gift certificates for participating. One subject says,
Well, I guess if the drug doesn't work, I'll just have to put up with the symptoms for 6 months.
What will the nurse tell the subject?
a. Participation for the duration of the study is required.
b. Participation may end at any time without penalty.
c. Withdrawal from the study may end at any time, but the gift certificate will not be given.
d. You can request placement in the treatment group.
